segment 2: molecular targets in nsclc
Published 10 years ago • 1.9K plays • Length 26:57Download video MP4
Download video MP3
Similar videos
-
5:16
understanding the molecular targets of nsclc
-
33:52
keynote lecture: targeted therapies in lung cancer 2.0 – advances and promises
-
22:45
segment 3: novel targets and agents in lung cancer
-
20:47
targeting signaling pathways in nsclc 2 - socinski
-
5:40
nsclc: promising molecular targets
-
21:10
targeting her2, braf, kras, met
-
28:17
segment 1: egfr tkis in nsclc
-
22:54
investigator insights segment 2: early clinical trials in hgf and c-met targeted therapy
-
3:27
emerging molecular targets for advanced non small cell lung cancer nsclc
-
6:43
molecular testing in patients with metastatic nsclc
-
5:21
molecular testing and actionable targets in lung cancer
-
18:41
extreme rare mutations in lung cancer (ros1, trk, her2): treatment opportunities
-
30:18
segment 4: panel case discussions
-
44:56
advanced nsclc: refining clinical pathways in the rapidly evolving therapeutic landscape
-
16:35
heterogeneity of nsclc and precipitating oncogenic driver mutations
-
22:06
basics of immunotherapy in nsclc
-
3:46
cap/iaslc/amp 2018 nsclc molecular testing guidelines: nsclc testing guidelines
-
17:10
sclc: therapeutic progress or mirage?
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning